LISA KNUFFMAN, CNP
Nurse Practitioner · QUINCY, IL
Individual Active NPI 1609000439
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 412 | 75,329 | $4,561,940 | $1,821,958 | $1,446,045 |
| 2023 | 415 | 98,889 | $5,238,801 | $1,913,142 | $1,520,366 |
| 2022 | 429 | 76,659 | $3,034,995 | $1,248,683 | $990,100 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 8,600 | $56 | $45 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,800 | $3 | $2 |
| J1453 | Injection, fosaprepitant, 1 mg | 5,700 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 2,520 | $25 | $20 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 896 | $0 | $0 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 614 | $103 | $76 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 510 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 490 | $0 | $0 |
| Q5111 | Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 288 | $138 | $110 |
| J3480 | Injection, potassium chloride, per 2 meq | 240 | $0 | $0 |
| 96375 | Injection of additional new drug or substance into vein | 176 | $12 | $10 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 174 | $100 | $79 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Nurse Practitioner | 363L00000X | ✓ | 209007581 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Nurse Practitioner providers in Illinois
- NPI 1275866600
- NPI 1528957867
- NPI 1518571546
- NPI 1417204827
- NPI 1215351390
- NPI 1306810932
- NPI 1366174393
- NPI 1396718987
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.